ArticleDiagnostics (Basel, Switzerland)2025
Associations Between Th17 Cell Markers (IL-23R, CCR6, and IL-17) and Clinical Profiles in Sjögren's Disease.
Erika Fabiola López-Villalobos, Jose Antonio Garcia-Espinoza, Mariel García-Chagollán, Jefte Felipe Uribe-Martínez, Sergio Cerpa-Cruz, José Francisco Muñoz-Valle, Claudia Azucena Palafox-Sánchez, Edith Oregon-Romero
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Erika Fabiola López-VillalobosDoctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Jose Antonio Garcia-EspinozaDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Coyoacán 04510, Ciudad de México, Mexico.ORCID 0000-0001-6050-5471 Mariel García-ChagollánInstituto de Investigación en Ciencias Biomédicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44430, Jalisco, Mexico.
Jefte Felipe Uribe-MartínezServicio de Reumatología, Hospital Civil "Fray Antonio Alcalde", Guadalajara 44200, Jalisco, Mexico.
Sergio Cerpa-CruzServicio de Reumatología, Hospital Civil "Fray Antonio Alcalde", Guadalajara 44200, Jalisco, Mexico.
José Francisco Muñoz-ValleInstituto de Investigación en Ciencias Biomédicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44430, Jalisco, Mexico.ORCID 0000-0002-2272-9260 Claudia Azucena Palafox-SánchezInstituto de Investigación en Ciencias Biomédicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44430, Jalisco, Mexico.ORCID 0000-0003-0836-4186 Edith Oregon-RomeroInstituto de Investigación en Ciencias Biomédicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44430, Jalisco, Mexico.ORCID 0000-0001-6010-0837 Funding
Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI) 273324
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cytokine profilingflow cytometryIL-23R+ T cellsimmunophenotypinglipid metabolismSjögren’s diseaseTh17 cell heterogeneity
Identifiers
PMID41300932
PMCPMC12651690
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390